SMMT
NASDAQStockSummit Therapeutics Inc.
$16.07+0.60 (+3.91%)
52-Week Range
$13.85
$36.70
Key Stats
Market Cap
12.0B
P/E Ratio
—
Dividend Yield
—
Beta
-1.39
Volume
2.0M
Avg Volume
2.1M
Performance
1M
+5.67%
3M
-11.05%
6M
-18.37%
YTD
-11.76%
1Y
-25.64%
3Y
+842.68%
5Y
+141.56%
Price Chart
ETF Exposure
SMMT is held by 88 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| CANC | Tema Oncology ETF | 1.13% |
| CURE.AX | Global X - S&P Biotech ETF | 0.97% |
| XBI | State Street SPDR S&P Biotech ETF | 0.97% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | 0.92% |
| SBIO.L | Invesco NASDAQ Biotech UCITS ETF | 0.92% |
| BBC | Virtus Biotech Clinical Trials ETF | 0.68% |
| BIB | ProShares - Ultra Nasdaq Biotechnology | 0.64% |
| QQQJ | Invesco NASDAQ Next Gen 100 ETF | 0.60% |
| EQJS.L | Invesco NASDAQ Next Generation 100 UCITS ETF | 0.60% |
| BMED | iShares Health Innovation Active ETF | 0.51% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.38% |
| QQJG | Invesco ESG NASDAQ Next Gen 100 ETF | 0.30% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.21% |
| PWS | Pacer WealthShield ETF | 0.21% |
| IBB | iShares Biotechnology ETF | 0.14% |
| IQSM | NYLI Candriam U.S. Mid Cap Equity ETF | 0.14% |
| EQAL | Invesco Russell 1000 Equal Weight ETF | 0.08% |
| PTL | Inspire 500 ETF | 0.07% |
| IWP | iShares Russell Mid-Cap Growth ETF | 0.07% |
| BKMC | BNY Mellon US Mid Cap Core Equity ETF | 0.05% |
| SCHM | Schwab U.S. Mid-Cap ETF | 0.05% |
| STXM | Strive Mid-Cap ETF | 0.05% |
| BBMC | JPMorgan BetaBuilders U.S. Mid Cap Equity ETF | 0.04% |
| VBR | Vanguard Small-Cap Value ETF | 0.04% |
| IYH | iShares U.S. Healthcare ETF | 0.03% |
| VHT | Vanguard Health Care ETF | 0.03% |
| ONEQ | FIDELITY NASDAQ COMPOSITE INDEX ETF | 0.03% |
| IMCG | iShares Morningstar Mid-Cap Growth ETF | 0.03% |
| JKH | iShares Morningstar Mid-Cap Growth ETF | 0.03% |
| VXF | Vanguard Extended Market ETF | 0.03% |
| SMMD | iShares Russell 2500 ETF | 0.03% |
| VB | Vanguard Small-Cap ETF | 0.02% |
| STXV | Strive 1000 Value ETF | 0.02% |
| IWR | iShares Russell Mid-Cap ETF | 0.01% |
| IMCB | iShares Morningstar Mid-Cap ETF | 0.01% |
| JKG | iShares Morningstar Mid-Cap ETF | 0.01% |
| REMC | Columbia Research Enhanced Mid Cap ETF | 0.01% |
| GGUS | Goldman Sachs MarketBeta Russell 1000 Growth Equity ETF | 0.01% |
| JHMM | John Hancock Investments - Multifactor Mid Cap ETF | 0.01% |
| SCHV | Schwab U.S. Large-Cap Value ETF | 0.01% |
| IWF | iShares Russell 1000 Growth ETF | 0.01% |
| ILCG | iShares Morningstar Growth ETF | 0.01% |
| JKE | iShares Morningstar Growth ETF | 0.01% |
| VONG | Vanguard Russell 1000 Growth ETF | 0.01% |
| IGDA.L | Invesco Dow Jones Islamic Global Developed Markets UCITS ETF | 0.00% |
| GUSA | Goldman Sachs MarketBeta US 1000 Equity ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| IYY | iShares Dow Jones U.S. ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| SCHK | Schwab 1000 Index ETF | 0.00% |
Page 1 of 2Next
About SMMT ETF Exposure
Summit Therapeutics Inc. (SMMT) is held by 88 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 12.0B, SMMT is a widely held institutional stock. The stock currently trades at $16.07. Investors can gain exposure to SMMT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold SMMT, sorted by portfolio weight.